Part of EMA highlights 2022 : Ebvallo (Atara/ Pierre Fabre) for the treatment of a blood cancer called Epstein-Barr virus positive post-transplant lymphoproliferative disease. This medicine is intended for adults and children who develop this malignancy after receiving an organor a bone marrow-transplantation. To know more
